24 related articles for article (PubMed ID: 2183884)
1. FIRST REPORTS OF CLINICAL PHARMACOKINETICS IN NIGERIA.
Michael OS
Ann Ib Postgrad Med; 2015 Jun; 13(1):48-53. PubMed ID: 26807087
[TBL] [Abstract][Full Text] [Related]
2. Influence of endogenous and exogenous effectors on the pharmacokinetics of theophylline. Focus on biotransformation.
Tröger U; Meyer FP
Clin Pharmacokinet; 1995 Apr; 28(4):287-314. PubMed ID: 7648758
[TBL] [Abstract][Full Text] [Related]
3. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
Murdoch D; Brogden RN
Drugs; 1991 May; 41(5):737-79. PubMed ID: 1712708
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic interactions between theophylline and other medication (Part II).
Upton RA
Clin Pharmacokinet; 1991 Feb; 20(2):135-50. PubMed ID: 1709398
[TBL] [Abstract][Full Text] [Related]
5. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcium channel blockers on theophylline disposition.
Sirmans SM; Pieper JA; Lalonde RL; Smith DG; Self TH
Clin Pharmacol Ther; 1988 Jul; 44(1):29-34. PubMed ID: 3391002
[TBL] [Abstract][Full Text] [Related]
7. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
Saitoh T; Kokue E; Shimoda M
J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of rifampicin-induced theophylline metabolism by diltiazem/rifampicin coadministration in healthy volunteers.
Adebayo GI; Akintonwa A; Mabadeje AF
Eur J Clin Pharmacol; 1989; 37(2):127-31. PubMed ID: 2792166
[TBL] [Abstract][Full Text] [Related]
9. Changes in antipyrine and indocyanine green kinetics during nifedipine, verapamil, and diltiazem therapy.
Bauer LA; Stenwall M; Horn JR; Davis R; Opheim K; Greene L
Clin Pharmacol Ther; 1986 Aug; 40(2):239-42. PubMed ID: 3731687
[TBL] [Abstract][Full Text] [Related]
10. Effect of nifedipine on antipyrine and theophylline disposition.
Adebayo GI; Mabadeje AF
Biopharm Drug Dispos; 1990 Mar; 11(2):157-64. PubMed ID: 2183884
[TBL] [Abstract][Full Text] [Related]
11. Calcium antagonists. Pharmacokinetic properties.
Kates RE
Drugs; 1983 Feb; 25(2):113-24. PubMed ID: 6339196
[TBL] [Abstract][Full Text] [Related]
12. Lack of pantoprazole drug interactions in man.
Steinijans VW; Huber R; Hartmann M; Zech K; Bliesath H; Wurst W; Radtke HW
Int J Clin Pharmacol Ther; 1994 Aug; 32(8):385-99. PubMed ID: 7981922
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
